Tumour suppression induced by the macrophage activating lipopeptide MALP-2 in an ultrasound guided pancreatic carcinoma mouse model
about
Development of an orthotopic human pancreatic cancer xenograft model using ultrasound guided injection of cells.Recombinant lipidated HPV E7 induces a Th-1-biased immune response and protective immunity against cervical cancer in a mouse model.Antioxidant N-acetylcysteine attenuates hepatocarcinogenesis by inhibiting ROS/ER stress in TLR2 deficient mouse.Intratumoural injection of the toll-like receptor-2/6 agonist 'macrophage-activating lipopeptide-2' in patients with pancreatic carcinoma: a phase I/II trial.Current developments, problems and solutions in the non-surgical treatment of pancreatic cancer.TLR agonists: our best frenemy in cancer immunotherapyMetastasis regulation by PPARD expression in cancer cells.Toll-like receptors as therapeutic targets in gastrointestinal diseases.Dysregulation of signaling pathways associated with innate antibacterial immunity in patients with pancreatic cancer.Adjuvants for enhancing the immunogenicity of whole tumor cell vaccines.Intervention on toll-like receptors in pancreatic cancer.Clinically feasible approaches to potentiating cancer cell-based immunotherapies.Activation of Toll-like receptor 2 by a novel preparation of cell wall skeleton from Mycobacterium bovis BCG Tokyo (SMP-105) sufficiently enhances immune responses against tumors.The TLR-2/TLR-6 agonist macrophage-activating lipopeptide-2 augments human NK cell cytotoxicity when PGE2 production by monocytes is inhibited by a COX-2 blocker.Stimulation of pulmonary immune responses by the TLR2/6 agonist MALP-2 and effect on melanoma metastasis to the lung.Myeloid-derived macrophages and secreted HSP90α induce pancreatic ductal adenocarcinoma development.Type I Interferon-Independent Dendritic Cell Priming and Antitumor T Cell Activation Induced by a Mycoplasma fermentans Lipopeptide.
P2860
Q30475224-A04AD440-520F-49CF-A274-F69481D15E33Q34345467-313E9673-F015-4E3E-B5BF-0DCED2F16EE7Q35008938-29011277-E827-428E-9CD8-14AB7B37323EQ36611097-C661E2A5-B6E3-4CBE-95AA-271780A84E2AQ36733001-63EFF7DD-9370-4C62-872E-CD73683393F3Q36850457-3DBB8C66-8FB3-4848-B73F-691939F5033DQ37559645-B12A7D1C-C659-4F28-917C-9BA39C26A283Q37690323-D9BD87A3-589F-4E1C-A102-088A84446D57Q37739809-4895E9D3-0C17-4719-88AE-603D03BF1ED1Q37873932-DA6655D8-A71B-4806-9043-C523845EA65CQ38219023-098FA28A-4E17-4A2C-B4B3-DB5A432660B0Q38453610-01980FFA-A97F-4B96-ACEE-9E320EA9332FQ39985973-37DA79CD-CCC5-4467-98B9-9FEDB5242255Q40876421-B9198343-91CE-4217-936E-72A9D276868AQ48756180-E7F60198-7E75-475C-AC74-C6720E36F33FQ52714316-B81D840D-0976-49AA-B853-1D9EBBA8E351Q55401761-8D9E52C7-9C70-4AC8-9667-634BA8D555FC
P2860
Tumour suppression induced by the macrophage activating lipopeptide MALP-2 in an ultrasound guided pancreatic carcinoma mouse model
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Tumour suppression induced by ...... ncreatic carcinoma mouse model
@ast
Tumour suppression induced by ...... ncreatic carcinoma mouse model
@en
type
label
Tumour suppression induced by ...... ncreatic carcinoma mouse model
@ast
Tumour suppression induced by ...... ncreatic carcinoma mouse model
@en
prefLabel
Tumour suppression induced by ...... ncreatic carcinoma mouse model
@ast
Tumour suppression induced by ...... ncreatic carcinoma mouse model
@en
P2093
P2860
P356
P1433
P1476
Tumour suppression induced by ...... ncreatic carcinoma mouse model
@en
P2093
C Schneider
I G H Schmidt-Wolf
P F Mühlradt
T Sauerbruch
P2860
P304
P356
10.1136/GUT.2003.026005
P407
P577
2004-03-01T00:00:00Z